{
    "info": {
        "nct_id": "NCT06066437",
        "official_title": "NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trial",
        "inclusion_criteria": "1. Men ≥18 years of age\n2. Histologically documented prostatic adenocarcinoma with an NCCN risk group of high-risk or very high-risk. NCCN High Risk and Very High-Risk criteria shown below. (Network, N.C.C. (2021).\n\n   Prostate Cancer (Version 02.2021).\n\n   High Risk:\n   * Has no very-high-risk features and has exactly one high-risk feature:\n   * cT3a\n   * Grade Group 4 or Grade Group 5\n   * PSA >20 ng/mL\n\n   Very high:\n   * Has at least one of the following:\n   * cT3b-cT4\n   * Primary Gleason pattern 5\n   * 2 or 3 high-risk features\n   * >4 cores with Grade Group 4 or 5\n3. Prostate biopsy within 90 days prior to randomization is allowed for entry requirements. Prostate biopsy must be reviewed at MD Anderson Cancer Center. Patients with small cell, neuroendocrine, or transitional cell carcinomas are not eligible\n4. ECOG performance status (PS) grade 1\n5. No evidence of metastatic disease or clinically positive lymph nodes as documented by technetium99m (99mTc) bone scan and by computed tomography (CT) or magnetic resonance imaging (MRI) scans. Imaging may be obtained up to 60 days prior to randomization\n6. Minimum prostate tumor volume of 1.5 cm3 or greater as measured on prostate MRI within 60 days prior to randomization\n7. Distant metastatic disease or clinically positive lymph nodes not identified by conventional imaging including by technetium-99m (99mTc) bone scan and by computed tomography (CT) or magnetic resonance imaging (MRI) scans but identified PSMA PET is allowed based on provider discretion\n8. PSMA expression within the primary tumor with a minimum SUVmax of the primary tumor of at least 8\n9. Localized or locally advanced disease deemed by the surgeon to be resectable. Patients must be appropriate candidates for and plan to undergo radical prostatectomy and pelvic lymph node dissection\n10. No prior treatment for prostate cancer including prior surgery (excluding transurethral resection of the prostate [TURP]), cryoablation, pelvic lymph node dissection, radiation therapy, hormonal therapy or chemotherapy\n11. Adequate bone marrow function documented by:\n\n    * Hemoglobin ≥11 g/dL\n    * Absolute neutrophil count ≥1.5 x 109/L\n    * Platelet count ≥150 x 109/L\n12. Adequate renal function defined as creatinine <1.5 x ULN or estimated glomerular filtration rate >60 mL/min/1.73 m2 using BSA with CKD-EPI\n13. Adequate hepatic function documented by:\n\n    * Total bilirubin ≤1.5 x ULN\n    * AST ≤2.5 x ULN\n    * ALT ≤2.5 x ULN\n    * Alkaline Phosphatase (ALP) ≤2.5 x ULN\n\n    Patients with Gilbert's syndrome do not need to meet total bilirubin requirements provided their total bilirubin is not greater than their historical level. Gilbert's syndrome must be documented appropriately as past medical history\n14. Consents to providing whole blood samples for correlative PSMA evaluation of circulating tumor cells and extra cellular vesicles\n15. Willing and able to comply with clinic visits and study-related procedures\n16. Provide informed consent signed by study patient\n17. To avoid risk of drug exposure through the ejaculate (even men with vasectomies), subjects must use a condom during sexual activity while on study drug and for 6 months following the last dose of study drug. If the subject is engaged in sexual activity with a woman of childbearing potential, a condom is required along with another effective contraceptive method consistent with local regulations regarding the use of birth control methods for subjects participating in clinical studies and their partners. Donation of sperm is not allowed while on study drug and for 3 months following the last dose of study drug.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "1. Prior hormone therapy for prostate cancer including orchiectomy, antiandrogens, ketoconazole, or estrogens (5-α reductase inhibitors allowed), or LHRH agonists/antagonists\n2. Currently enrolled in another interventional study\n3. Concurrent treatment with systemic corticosteroids (prednisone dose >10 mg per day or equivalent) or other immunosuppressive drugs <14 days prior to treatment initiation Steroids that are topical, inhaled, nasal (spray), or ophthalmic solution are permitted.\n4. Known evidence of an active infection requiring systemic therapy such as uncontrolled human immunodeficiency virus (HIV), active hepatitis, or fungal infection. Uncomplicated urinary tract infection (UTI) does not qualify as an excluding infection.\n\n   * Patients with HIV must be on an effective anti-retroviral regimen atleast four weeks prior to enrollment, HIV viral load less than 400 copies/mL and CD4+ T cell counts greater than 350 cell/uL.\n   * Patients with HIV must agree to adhere to anti-retroviral therapy for the entirety of their participation in the protocol unless dictated by treatment toxicities.\n   * Patients on Tenofovir will be excluded as there is a known risk of proximal renal tubule dysfunction leading to renal toxicity. Given that PSMA is expressed on the proximal tubule there is a theoretical risk of overlapping toxicity.\n5. History of clinically significant cardiovascular disease including, but not limited to:\n\n   * Myocardial infarction or unstable angina ≤6 months prior to treatment initiation\n   * Clinically significant cardiac arrhythmia\n   * Deep vein thrombosis, pulmonary embolism, stroke ≤6 months prior to treatment initiation\n   * Congestive heart failure (New York Heart Association class III-IV)\n   * Pericarditis/clinically significant pericardial effusion\n   * Myocarditis\n   * Endocarditis\n6. History of major implant(s) or device(s), including but not limited to:\n\n   * Prosthetic heart valve(s)\n   * Current or prior history of infection or other clinically significant adverse event associated with an exogenous implant or device that cannot be removed\n7. Other prior malignancy (exceptions: adequately treated basal cell or squamous cell skin cancer, superficial bladder cancer, or any other cancer in situ currently in complete remission) ≤2 years prior to enrollment\n8. Has received major surgery within 90 days of first administration of study drug\n9. Prior allogeneic stem cell transplantation or recipients of organ transplants or autologous stem cell transplantation at any time MD Anderson Protocol Number: 2022-0500 2022-0500 Version Date 8/29/2023 26\n10. Any medical, psychological or social condition that in the opinion of the investigator, would preclude participation in this study\n11. Previously received external beam irradiation to the pelvis or to a field that includes more than 30% of the bone marrow or kidneys\n12. Previous treatment with any of the following: PSMA-targeted radionuclide therapy, Strontium-89, Samarium-153, Rhenium-186, Rhenium-188, Radium-223, hemi-body irradiation\n13. Transfusion of blood products for the sole purpose of meeting the eligibility criteria for this clinical trial\n14. Patient has a functionally or anatomically solitary kidney.\n15. Patients with Hydronephrosis and a Mag3 Lasix Renogram that demonstrates objective urinary obstruction.",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "identified_line": {
                "line": "* AST ≤2.5 x ULN",
                "criterions": [
                    {
                        "exact_snippets": "AST ≤2.5 x ULN",
                        "criterion": "AST level",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2.5,
                                "unit": "x ULN"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "AST ≤2.5 x ULN",
                        "criterion": "AST level",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2.5,
                                "unit": "x ULN"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* cT3b-cT4",
                "criterions": [
                    {
                        "exact_snippets": "cT3b-cT4",
                        "criterion": "clinical tumor stage (cT)",
                        "requirement": {
                            "requirement_type": "stage",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 3,
                                        "unit": "T"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 4,
                                        "unit": "T"
                                    }
                                ]
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "cT3b-cT4",
                        "criterion": "clinical tumor stage (cT)",
                        "requirement": {
                            "requirement_type": "stage",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 3,
                                        "unit": "T"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 4,
                                        "unit": "T"
                                    }
                                ]
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "Healthy volunteers allowed",
                "criterions": [
                    {
                        "exact_snippets": "Healthy volunteers allowed",
                        "criterion": "healthy volunteer status",
                        "requirement": {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Healthy volunteers allowed",
                        "criterion": "healthy volunteer status",
                        "requirement": {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* cT3a",
                "criterions": [
                    {
                        "exact_snippets": "cT3a",
                        "criterion": "tumor clinical stage",
                        "requirement": {
                            "requirement_type": "stage",
                            "expected_value": "cT3a"
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "cT3a",
                        "criterion": "tumor clinical stage",
                        "requirement": {
                            "requirement_type": "stage",
                            "expected_value": "cT3a"
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "4. ECOG performance status (PS) grade 1",
                "criterions": [
                    {
                        "exact_snippets": "ECOG performance status (PS) grade 1",
                        "criterion": "ECOG performance status",
                        "requirement": {
                            "requirement_type": "grade",
                            "expected_value": {
                                "operator": "=",
                                "value": 1,
                                "unit": ""
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "ECOG performance status (PS) grade 1",
                        "criterion": "ECOG performance status",
                        "requirement": {
                            "requirement_type": "grade",
                            "expected_value": {
                                "operator": "=",
                                "value": 1,
                                "unit": ""
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "Must have minimum age of 18 Years",
                "criterions": [
                    {
                        "exact_snippets": "minimum age of 18 Years",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "minimum age of 18 Years",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Absolute neutrophil count ≥1.5 x 109/L",
                "criterions": [
                    {
                        "exact_snippets": "Absolute neutrophil count ≥1.5 x 109/L",
                        "criterion": "absolute neutrophil count",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1.5,
                                "unit": "x 10^9/L"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Absolute neutrophil count ≥1.5 x 109/L",
                        "criterion": "absolute neutrophil count",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1.5,
                                "unit": "x 10^9/L"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Total bilirubin ≤1.5 x ULN",
                "criterions": [
                    {
                        "exact_snippets": "Total bilirubin ≤1.5 x ULN",
                        "criterion": "total bilirubin",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1.5,
                                "unit": "x ULN"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Total bilirubin ≤1.5 x ULN",
                        "criterion": "total bilirubin",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1.5,
                                "unit": "x ULN"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "11. Adequate bone marrow function documented by:",
                "criterions": [
                    {
                        "exact_snippets": "Adequate bone marrow function",
                        "criterion": "bone marrow function",
                        "requirement": {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Adequate bone marrow function",
                        "criterion": "bone marrow function",
                        "requirement": {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* PSA >20 ng/mL",
                "criterions": [
                    {
                        "exact_snippets": "PSA >20 ng/mL",
                        "criterion": "PSA",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 20,
                                "unit": "ng/mL"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "PSA >20 ng/mL",
                        "criterion": "PSA",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 20,
                                "unit": "ng/mL"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "16. Provide informed consent signed by study patient",
                "criterions": [
                    {
                        "exact_snippets": "Provide informed consent signed by study patient",
                        "criterion": "informed consent",
                        "requirement": {
                            "requirement_type": "signed",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Provide informed consent signed by study patient",
                        "criterion": "informed consent",
                        "requirement": {
                            "requirement_type": "signed_by",
                            "expected_value": "study patient"
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Provide informed consent signed by study patient",
                        "criterion": "informed consent",
                        "requirement": {
                            "requirement_type": "signed",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Provide informed consent signed by study patient",
                        "criterion": "informed consent",
                        "requirement": {
                            "requirement_type": "signed_by",
                            "expected_value": "study patient"
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "12. Adequate renal function defined as creatinine <1.5 x ULN or estimated glomerular filtration rate >60 mL/min/1.73 m2 using BSA with CKD-EPI",
                "criterions": [
                    {
                        "exact_snippets": "creatinine <1.5 x ULN",
                        "criterion": "serum creatinine",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 1.5,
                                "unit": "x ULN"
                            }
                        }
                    },
                    {
                        "exact_snippets": "estimated glomerular filtration rate >60 mL/min/1.73 m2 using BSA with CKD-EPI",
                        "criterion": "estimated glomerular filtration rate (eGFR)",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 60,
                                "unit": "mL/min/1.73 m2"
                            }
                        }
                    },
                    {
                        "exact_snippets": "estimated glomerular filtration rate >60 mL/min/1.73 m2 using BSA with CKD-EPI",
                        "criterion": "estimated glomerular filtration rate (eGFR)",
                        "requirement": {
                            "requirement_type": "calculation_method",
                            "expected_value": "using BSA with CKD-EPI"
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "creatinine <1.5 x ULN",
                                "criterion": "serum creatinine",
                                "requirement": {
                                    "requirement_type": "quantity",
                                    "expected_value": {
                                        "operator": "<",
                                        "value": 1.5,
                                        "unit": "x ULN"
                                    }
                                }
                            }
                        ]
                    },
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "estimated glomerular filtration rate >60 mL/min/1.73 m2 using BSA with CKD-EPI",
                                "criterion": "estimated glomerular filtration rate (eGFR)",
                                "requirement": {
                                    "requirement_type": "quantity",
                                    "expected_value": {
                                        "operator": ">",
                                        "value": 60,
                                        "unit": "mL/min/1.73 m2"
                                    }
                                }
                            },
                            {
                                "exact_snippets": "estimated glomerular filtration rate >60 mL/min/1.73 m2 using BSA with CKD-EPI",
                                "criterion": "estimated glomerular filtration rate (eGFR)",
                                "requirement": {
                                    "requirement_type": "calculation_method",
                                    "expected_value": "using BSA with CKD-EPI"
                                }
                            }
                        ]
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "8. PSMA expression within the primary tumor with a minimum SUVmax of the primary tumor of at least 8",
                "criterions": [
                    {
                        "exact_snippets": "PSMA expression within the primary tumor",
                        "criterion": "PSMA expression in primary tumor",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "minimum SUVmax of the primary tumor of at least 8",
                        "criterion": "SUVmax of primary tumor",
                        "requirement": {
                            "requirement_type": "minimum value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 8,
                                "unit": "N/A"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "PSMA expression within the primary tumor",
                        "criterion": "PSMA expression in primary tumor",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "minimum SUVmax of the primary tumor of at least 8",
                        "criterion": "SUVmax of primary tumor",
                        "requirement": {
                            "requirement_type": "minimum value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 8,
                                "unit": "N/A"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "15. Willing and able to comply with clinic visits and study-related procedures",
                "criterions": [
                    {
                        "exact_snippets": "Willing and able to comply with clinic visits and study-related procedures",
                        "criterion": "compliance with clinic visits and study-related procedures",
                        "requirement": {
                            "requirement_type": "willingness",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Willing and able to comply with clinic visits and study-related procedures",
                        "criterion": "compliance with clinic visits and study-related procedures",
                        "requirement": {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Willing and able to comply with clinic visits and study-related procedures",
                        "criterion": "compliance with clinic visits and study-related procedures",
                        "requirement": {
                            "requirement_type": "willingness",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Willing and able to comply with clinic visits and study-related procedures",
                        "criterion": "compliance with clinic visits and study-related procedures",
                        "requirement": {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Has no very-high-risk features and has exactly one high-risk feature:",
                "criterions": [
                    {
                        "exact_snippets": "Has no very-high-risk features",
                        "criterion": "very-high-risk features",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "has exactly one high-risk feature",
                        "criterion": "high-risk features",
                        "requirement": {
                            "requirement_type": "count",
                            "expected_value": {
                                "operator": "=",
                                "value": 1,
                                "unit": "feature"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Has no very-high-risk features",
                        "criterion": "very-high-risk features",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "has exactly one high-risk feature",
                        "criterion": "high-risk features",
                        "requirement": {
                            "requirement_type": "count",
                            "expected_value": {
                                "operator": "=",
                                "value": 1,
                                "unit": "feature"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Has at least one of the following:",
                "criterions": [
                    {
                        "exact_snippets": "at least one of the following",
                        "criterion": "presence of at least one of a list of conditions",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "at least one of the following",
                        "criterion": "presence of at least one of a list of conditions",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "Very high:",
                "criterions": []
            },
            "logical_structure": {
                "and_criteria": []
            }
        },
        {
            "identified_line": {
                "line": "* 2 or 3 high-risk features",
                "criterions": [
                    {
                        "exact_snippets": "2 or 3 high-risk features",
                        "criterion": "number of high-risk features",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 2,
                                        "unit": "N/A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 3,
                                        "unit": "N/A"
                                    }
                                ]
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "2 or 3 high-risk features",
                        "criterion": "number of high-risk features",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 2,
                                        "unit": "N/A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 3,
                                        "unit": "N/A"
                                    }
                                ]
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "Prostate Cancer (Version 02.2021).",
                "criterions": [
                    {
                        "exact_snippets": "Prostate Cancer",
                        "criterion": "prostate cancer",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Prostate Cancer",
                        "criterion": "prostate cancer",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Primary Gleason pattern 5",
                "criterions": [
                    {
                        "exact_snippets": "Primary Gleason pattern 5",
                        "criterion": "Gleason pattern",
                        "requirement": {
                            "requirement_type": "primary pattern",
                            "expected_value": "5"
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Primary Gleason pattern 5",
                        "criterion": "Gleason pattern",
                        "requirement": {
                            "requirement_type": "primary pattern",
                            "expected_value": "5"
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "Patients with Gilbert's syndrome do not need to meet total bilirubin requirements provided their total bilirubin is not greater than their historical level. Gilbert's syndrome must be documented appropriately as past medical history",
                "criterions": [
                    {
                        "exact_snippets": "Patients with Gilbert's syndrome do not need to meet total bilirubin requirements provided their total bilirubin is not greater than their historical level",
                        "criterion": "total bilirubin",
                        "requirement": {
                            "requirement_type": "comparison to historical level",
                            "expected_value": "not greater than historical level"
                        }
                    },
                    {
                        "exact_snippets": "Gilbert's syndrome must be documented appropriately as past medical history",
                        "criterion": "Gilbert's syndrome documentation",
                        "requirement": {
                            "requirement_type": "documentation in past medical history",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "condition": {
                            "and_criteria": [
                                {
                                    "exact_snippets": "Gilbert's syndrome must be documented appropriately as past medical history",
                                    "criterion": "Gilbert's syndrome documentation",
                                    "requirement": {
                                        "requirement_type": "documentation in past medical history",
                                        "expected_value": true
                                    }
                                }
                            ]
                        },
                        "then_criteria": {
                            "and_criteria": [
                                {
                                    "exact_snippets": "Patients with Gilbert's syndrome do not need to meet total bilirubin requirements provided their total bilirubin is not greater than their historical level",
                                    "criterion": "total bilirubin",
                                    "requirement": {
                                        "requirement_type": "comparison to historical level",
                                        "expected_value": "not greater than historical level"
                                    }
                                }
                            ]
                        },
                        "else_criteria": null
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* ALT ≤2.5 x ULN",
                "criterions": [
                    {
                        "exact_snippets": "ALT ≤2.5 x ULN",
                        "criterion": "ALT (alanine aminotransferase) level",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2.5,
                                "unit": "x ULN"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "ALT ≤2.5 x ULN",
                        "criterion": "ALT (alanine aminotransferase) level",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2.5,
                                "unit": "x ULN"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Alkaline Phosphatase (ALP) ≤2.5 x ULN",
                "criterions": [
                    {
                        "exact_snippets": "Alkaline Phosphatase (ALP) ≤2.5 x ULN",
                        "criterion": "Alkaline Phosphatase (ALP) level",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2.5,
                                "unit": "x ULN"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Alkaline Phosphatase (ALP) ≤2.5 x ULN",
                        "criterion": "Alkaline Phosphatase (ALP) level",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2.5,
                                "unit": "x ULN"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "14. Consents to providing whole blood samples for correlative PSMA evaluation of circulating tumor cells and extra cellular vesicles",
                "criterions": [
                    {
                        "exact_snippets": "Consents to providing whole blood samples",
                        "criterion": "consent to provide whole blood samples",
                        "requirement": {
                            "requirement_type": "consent",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "correlative PSMA evaluation of circulating tumor cells",
                        "criterion": "PSMA evaluation of circulating tumor cells",
                        "requirement": {
                            "requirement_type": "evaluation",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "correlative PSMA evaluation of ... extra cellular vesicles",
                        "criterion": "PSMA evaluation of extracellular vesicles",
                        "requirement": {
                            "requirement_type": "evaluation",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Consents to providing whole blood samples",
                        "criterion": "consent to provide whole blood samples",
                        "requirement": {
                            "requirement_type": "consent",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "correlative PSMA evaluation of circulating tumor cells",
                        "criterion": "PSMA evaluation of circulating tumor cells",
                        "requirement": {
                            "requirement_type": "evaluation",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "correlative PSMA evaluation of ... extra cellular vesicles",
                        "criterion": "PSMA evaluation of extracellular vesicles",
                        "requirement": {
                            "requirement_type": "evaluation",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "13. Adequate hepatic function documented by:",
                "criterions": [
                    {
                        "exact_snippets": "Adequate hepatic function",
                        "criterion": "hepatic function",
                        "requirement": {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Adequate hepatic function",
                        "criterion": "hepatic function",
                        "requirement": {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Grade Group 4 or Grade Group 5",
                "criterions": [
                    {
                        "exact_snippets": "Grade Group 4",
                        "criterion": "Grade Group",
                        "requirement": {
                            "requirement_type": "value",
                            "expected_value": "4"
                        }
                    },
                    {
                        "exact_snippets": "Grade Group 5",
                        "criterion": "Grade Group",
                        "requirement": {
                            "requirement_type": "value",
                            "expected_value": "5"
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Grade Group 4",
                        "criterion": "Grade Group",
                        "requirement": {
                            "requirement_type": "value",
                            "expected_value": "4"
                        }
                    },
                    {
                        "exact_snippets": "Grade Group 5",
                        "criterion": "Grade Group",
                        "requirement": {
                            "requirement_type": "value",
                            "expected_value": "5"
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "17. To avoid risk of drug exposure through the ejaculate (even men with vasectomies), subjects must use a condom during sexual activity while on study drug and for 6 months following the last dose of study drug. If the subject is engaged in sexual activity with a woman of childbearing potential, a condom is required along with another effective contraceptive method consistent with local regulations regarding the use of birth control methods for subjects participating in clinical studies and their partners. Donation of sperm is not allowed while on study drug and for 3 months following the last dose of study drug.",
                "criterions": [
                    {
                        "exact_snippets": "subjects must use a condom during sexual activity while on study drug and for 6 months following the last dose of study drug",
                        "criterion": "condom use during sexual activity",
                        "requirement": {
                            "requirement_type": "duration",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": "while on study drug"
                                    },
                                    {
                                        "operator": ">=",
                                        "value": 6,
                                        "unit": "months after last dose"
                                    }
                                ]
                            }
                        }
                    },
                    {
                        "exact_snippets": "If the subject is engaged in sexual activity with a woman of childbearing potential, a condom is required along with another effective contraceptive method",
                        "criterion": "contraceptive use during sexual activity with a woman of childbearing potential",
                        "requirement": {
                            "requirement_type": "condom use",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "If the subject is engaged in sexual activity with a woman of childbearing potential, a condom is required along with another effective contraceptive method",
                        "criterion": "contraceptive use during sexual activity with a woman of childbearing potential",
                        "requirement": {
                            "requirement_type": "additional effective contraceptive method",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Donation of sperm is not allowed while on study drug and for 3 months following the last dose of study drug",
                        "criterion": "sperm donation",
                        "requirement": {
                            "requirement_type": "prohibition",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Donation of sperm is not allowed while on study drug and for 3 months following the last dose of study drug",
                        "criterion": "sperm donation",
                        "requirement": {
                            "requirement_type": "duration",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": "while on study drug"
                                    },
                                    {
                                        "operator": ">=",
                                        "value": 3,
                                        "unit": "months after last dose"
                                    }
                                ]
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "subjects must use a condom during sexual activity while on study drug and for 6 months following the last dose of study drug",
                                "criterion": "condom use during sexual activity",
                                "requirement": {
                                    "requirement_type": "duration",
                                    "expected_value": {
                                        "comparisons": [
                                            {
                                                "operator": ">=",
                                                "value": 0,
                                                "unit": "while on study drug"
                                            },
                                            {
                                                "operator": ">=",
                                                "value": 6,
                                                "unit": "months after last dose"
                                            }
                                        ]
                                    }
                                }
                            },
                            {
                                "and_criteria": [
                                    {
                                        "exact_snippets": "Donation of sperm is not allowed while on study drug and for 3 months following the last dose of study drug",
                                        "criterion": "sperm donation",
                                        "requirement": {
                                            "requirement_type": "prohibition",
                                            "expected_value": true
                                        }
                                    },
                                    {
                                        "exact_snippets": "Donation of sperm is not allowed while on study drug and for 3 months following the last dose of study drug",
                                        "criterion": "sperm donation",
                                        "requirement": {
                                            "requirement_type": "duration",
                                            "expected_value": {
                                                "comparisons": [
                                                    {
                                                        "operator": ">=",
                                                        "value": 0,
                                                        "unit": "while on study drug"
                                                    },
                                                    {
                                                        "operator": ">=",
                                                        "value": 3,
                                                        "unit": "months after last dose"
                                                    }
                                                ]
                                            }
                                        }
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "condition": {
                            "exact_snippets": "If the subject is engaged in sexual activity with a woman of childbearing potential, a condom is required along with another effective contraceptive method",
                            "criterion": "contraceptive use during sexual activity with a woman of childbearing potential",
                            "requirement": {
                                "requirement_type": "condom use",
                                "expected_value": true
                            }
                        },
                        "then_criteria": {
                            "and_criteria": [
                                {
                                    "exact_snippets": "If the subject is engaged in sexual activity with a woman of childbearing potential, a condom is required along with another effective contraceptive method",
                                    "criterion": "contraceptive use during sexual activity with a woman of childbearing potential",
                                    "requirement": {
                                        "requirement_type": "condom use",
                                        "expected_value": true
                                    }
                                },
                                {
                                    "exact_snippets": "If the subject is engaged in sexual activity with a woman of childbearing potential, a condom is required along with another effective contraceptive method",
                                    "criterion": "contraceptive use during sexual activity with a woman of childbearing potential",
                                    "requirement": {
                                        "requirement_type": "additional effective contraceptive method",
                                        "expected_value": true
                                    }
                                }
                            ]
                        },
                        "else_criteria": null
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "High Risk:",
                "criterions": [
                    {
                        "exact_snippets": "High Risk:",
                        "criterion": "risk level",
                        "requirement": {
                            "requirement_type": "level",
                            "expected_value": "high"
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "High Risk:",
                        "criterion": "risk level",
                        "requirement": {
                            "requirement_type": "level",
                            "expected_value": "high"
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "6. Minimum prostate tumor volume of 1.5 cm3 or greater as measured on prostate MRI within 60 days prior to randomization",
                "criterions": [
                    {
                        "exact_snippets": "Minimum prostate tumor volume of 1.5 cm3 or greater as measured on prostate MRI",
                        "criterion": "prostate tumor volume",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1.5,
                                "unit": "cm3"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Minimum prostate tumor volume of 1.5 cm3 or greater as measured on prostate MRI",
                        "criterion": "prostate tumor volume",
                        "requirement": {
                            "requirement_type": "measurement_method",
                            "expected_value": "prostate MRI"
                        }
                    },
                    {
                        "exact_snippets": "prostate MRI within 60 days prior to randomization",
                        "criterion": "prostate MRI",
                        "requirement": {
                            "requirement_type": "timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 60,
                                "unit": "days prior to randomization"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Minimum prostate tumor volume of 1.5 cm3 or greater as measured on prostate MRI",
                        "criterion": "prostate tumor volume",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1.5,
                                "unit": "cm3"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Minimum prostate tumor volume of 1.5 cm3 or greater as measured on prostate MRI",
                        "criterion": "prostate tumor volume",
                        "requirement": {
                            "requirement_type": "measurement_method",
                            "expected_value": "prostate MRI"
                        }
                    },
                    {
                        "exact_snippets": "prostate MRI within 60 days prior to randomization",
                        "criterion": "prostate MRI",
                        "requirement": {
                            "requirement_type": "timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 60,
                                "unit": "days prior to randomization"
                            }
                        }
                    }
                ]
            }
        }
    ],
    "exclusion_lines": [
        {
            "identified_line": {
                "line": "5. History of clinically significant cardiovascular disease including, but not limited to:",
                "criterions": [
                    {
                        "exact_snippets": "History of clinically significant cardiovascular disease",
                        "criterion": "clinically significant cardiovascular disease",
                        "requirement": {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "History of clinically significant cardiovascular disease",
                        "criterion": "clinically significant cardiovascular disease",
                        "requirement": {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Clinically significant cardiac arrhythmia",
                "criterions": [
                    {
                        "exact_snippets": "Clinically significant cardiac arrhythmia",
                        "criterion": "cardiac arrhythmia",
                        "requirement": {
                            "requirement_type": "clinical significance",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Clinically significant cardiac arrhythmia",
                        "criterion": "cardiac arrhythmia",
                        "requirement": {
                            "requirement_type": "clinical significance",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "15. Patients with Hydronephrosis and a Mag3 Lasix Renogram that demonstrates objective urinary obstruction.",
                "criterions": [
                    {
                        "exact_snippets": "Patients with Hydronephrosis",
                        "criterion": "hydronephrosis",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Mag3 Lasix Renogram that demonstrates objective urinary obstruction",
                        "criterion": "urinary obstruction on Mag3 Lasix Renogram",
                        "requirement": {
                            "requirement_type": "demonstrated_by",
                            "expected_value": "Mag3 Lasix Renogram"
                        }
                    },
                    {
                        "exact_snippets": "Mag3 Lasix Renogram that demonstrates objective urinary obstruction",
                        "criterion": "urinary obstruction on Mag3 Lasix Renogram",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Patients with Hydronephrosis",
                        "criterion": "hydronephrosis",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Mag3 Lasix Renogram that demonstrates objective urinary obstruction",
                                "criterion": "urinary obstruction on Mag3 Lasix Renogram",
                                "requirement": {
                                    "requirement_type": "demonstrated_by",
                                    "expected_value": "Mag3 Lasix Renogram"
                                }
                            },
                            {
                                "exact_snippets": "Mag3 Lasix Renogram that demonstrates objective urinary obstruction",
                                "criterion": "urinary obstruction on Mag3 Lasix Renogram",
                                "requirement": {
                                    "requirement_type": "presence",
                                    "expected_value": true
                                }
                            }
                        ]
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "13. Transfusion of blood products for the sole purpose of meeting the eligibility criteria for this clinical trial",
                "criterions": [
                    {
                        "exact_snippets": "Transfusion of blood products for the sole purpose of meeting the eligibility criteria for this clinical trial",
                        "criterion": "transfusion of blood products",
                        "requirement": {
                            "requirement_type": "purpose",
                            "expected_value": "sole purpose of meeting the eligibility criteria for this clinical trial"
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Transfusion of blood products for the sole purpose of meeting the eligibility criteria for this clinical trial",
                        "criterion": "transfusion of blood products",
                        "requirement": {
                            "requirement_type": "purpose",
                            "expected_value": "sole purpose of meeting the eligibility criteria for this clinical trial"
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "6. History of major implant(s) or device(s), including but not limited to:",
                "criterions": [
                    {
                        "exact_snippets": "History of major implant(s) or device(s)",
                        "criterion": "major implant or device",
                        "requirement": {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "History of major implant(s) or device(s)",
                        "criterion": "major implant or device",
                        "requirement": {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Deep vein thrombosis, pulmonary embolism, stroke ≤6 months prior to treatment initiation",
                "criterions": [
                    {
                        "exact_snippets": "Deep vein thrombosis ... ≤6 months prior to treatment initiation",
                        "criterion": "deep vein thrombosis",
                        "requirement": {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    },
                    {
                        "exact_snippets": "pulmonary embolism ... ≤6 months prior to treatment initiation",
                        "criterion": "pulmonary embolism",
                        "requirement": {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    },
                    {
                        "exact_snippets": "stroke ≤6 months prior to treatment initiation",
                        "criterion": "stroke",
                        "requirement": {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Deep vein thrombosis ... ≤6 months prior to treatment initiation",
                        "criterion": "deep vein thrombosis",
                        "requirement": {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    },
                    {
                        "exact_snippets": "pulmonary embolism ... ≤6 months prior to treatment initiation",
                        "criterion": "pulmonary embolism",
                        "requirement": {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    },
                    {
                        "exact_snippets": "stroke ≤6 months prior to treatment initiation",
                        "criterion": "stroke",
                        "requirement": {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "3. Concurrent treatment with systemic corticosteroids (prednisone dose >10 mg per day or equivalent) or other immunosuppressive drugs <14 days prior to treatment initiation Steroids that are topical, inhaled, nasal (spray), or ophthalmic solution are permitted.",
                "criterions": [
                    {
                        "exact_snippets": "Concurrent treatment with systemic corticosteroids (prednisone dose >10 mg per day or equivalent) ... <14 days prior to treatment initiation",
                        "criterion": "systemic corticosteroid use",
                        "requirement": {
                            "requirement_type": "concurrent use",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Concurrent treatment with systemic corticosteroids (prednisone dose >10 mg per day or equivalent) ... <14 days prior to treatment initiation",
                        "criterion": "systemic corticosteroid use",
                        "requirement": {
                            "requirement_type": "drug",
                            "expected_value": "systemic corticosteroids"
                        }
                    },
                    {
                        "exact_snippets": "Concurrent treatment with systemic corticosteroids (prednisone dose >10 mg per day or equivalent) ... <14 days prior to treatment initiation",
                        "criterion": "systemic corticosteroid use",
                        "requirement": {
                            "requirement_type": "dose",
                            "expected_value": {
                                "operator": ">",
                                "value": 10,
                                "unit": "mg prednisone equivalent per day"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Concurrent treatment with systemic corticosteroids (prednisone dose >10 mg per day or equivalent) ... <14 days prior to treatment initiation",
                        "criterion": "systemic corticosteroid use",
                        "requirement": {
                            "requirement_type": "time before treatment initiation",
                            "expected_value": {
                                "operator": "<",
                                "value": 14,
                                "unit": "days"
                            }
                        }
                    },
                    {
                        "exact_snippets": "other immunosuppressive drugs <14 days prior to treatment initiation",
                        "criterion": "immunosuppressive drug use",
                        "requirement": {
                            "requirement_type": "concurrent use",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "other immunosuppressive drugs <14 days prior to treatment initiation",
                        "criterion": "immunosuppressive drug use",
                        "requirement": {
                            "requirement_type": "drug",
                            "expected_value": "other immunosuppressive drugs"
                        }
                    },
                    {
                        "exact_snippets": "other immunosuppressive drugs <14 days prior to treatment initiation",
                        "criterion": "immunosuppressive drug use",
                        "requirement": {
                            "requirement_type": "time before treatment initiation",
                            "expected_value": {
                                "operator": "<",
                                "value": 14,
                                "unit": "days"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Steroids that are topical, inhaled, nasal (spray), or ophthalmic solution are permitted.",
                        "criterion": "topical, inhaled, nasal, or ophthalmic steroid use",
                        "requirement": {
                            "requirement_type": "permitted use",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "and_criteria": [
                            {
                                "and_criteria": [
                                    {
                                        "exact_snippets": "Concurrent treatment with systemic corticosteroids (prednisone dose >10 mg per day or equivalent) ... <14 days prior to treatment initiation",
                                        "criterion": "systemic corticosteroid use",
                                        "requirement": {
                                            "requirement_type": "concurrent use",
                                            "expected_value": true
                                        }
                                    },
                                    {
                                        "exact_snippets": "Concurrent treatment with systemic corticosteroids (prednisone dose >10 mg per day or equivalent) ... <14 days prior to treatment initiation",
                                        "criterion": "systemic corticosteroid use",
                                        "requirement": {
                                            "requirement_type": "drug",
                                            "expected_value": "systemic corticosteroids"
                                        }
                                    },
                                    {
                                        "exact_snippets": "Concurrent treatment with systemic corticosteroids (prednisone dose >10 mg per day or equivalent) ... <14 days prior to treatment initiation",
                                        "criterion": "systemic corticosteroid use",
                                        "requirement": {
                                            "requirement_type": "dose",
                                            "expected_value": {
                                                "operator": ">",
                                                "value": 10,
                                                "unit": "mg prednisone equivalent per day"
                                            }
                                        }
                                    },
                                    {
                                        "exact_snippets": "Concurrent treatment with systemic corticosteroids (prednisone dose >10 mg per day or equivalent) ... <14 days prior to treatment initiation",
                                        "criterion": "systemic corticosteroid use",
                                        "requirement": {
                                            "requirement_type": "time before treatment initiation",
                                            "expected_value": {
                                                "operator": "<",
                                                "value": 14,
                                                "unit": "days"
                                            }
                                        }
                                    }
                                ]
                            },
                            {
                                "not_criteria": {
                                    "exact_snippets": "Steroids that are topical, inhaled, nasal (spray), or ophthalmic solution are permitted.",
                                    "criterion": "topical, inhaled, nasal, or ophthalmic steroid use",
                                    "requirement": {
                                        "requirement_type": "permitted use",
                                        "expected_value": true
                                    }
                                }
                            }
                        ]
                    },
                    {
                        "and_criteria": [
                            {
                                "and_criteria": [
                                    {
                                        "exact_snippets": "other immunosuppressive drugs <14 days prior to treatment initiation",
                                        "criterion": "immunosuppressive drug use",
                                        "requirement": {
                                            "requirement_type": "concurrent use",
                                            "expected_value": true
                                        }
                                    },
                                    {
                                        "exact_snippets": "other immunosuppressive drugs <14 days prior to treatment initiation",
                                        "criterion": "immunosuppressive drug use",
                                        "requirement": {
                                            "requirement_type": "drug",
                                            "expected_value": "other immunosuppressive drugs"
                                        }
                                    },
                                    {
                                        "exact_snippets": "other immunosuppressive drugs <14 days prior to treatment initiation",
                                        "criterion": "immunosuppressive drug use",
                                        "requirement": {
                                            "requirement_type": "time before treatment initiation",
                                            "expected_value": {
                                                "operator": "<",
                                                "value": 14,
                                                "unit": "days"
                                            }
                                        }
                                    }
                                ]
                            }
                        ]
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Myocarditis",
                "criterions": [
                    {
                        "exact_snippets": "Myocarditis",
                        "criterion": "myocarditis",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "not_criteria": {
                    "exact_snippets": "Myocarditis",
                    "criterion": "myocarditis",
                    "requirement": {
                        "requirement_type": "presence",
                        "expected_value": true
                    }
                }
            }
        },
        {
            "identified_line": {
                "line": "2. Currently enrolled in another interventional study",
                "criterions": [
                    {
                        "exact_snippets": "Currently enrolled in another interventional study",
                        "criterion": "enrollment in another interventional study",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Currently enrolled in another interventional study",
                        "criterion": "enrollment in another interventional study",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "11. Previously received external beam irradiation to the pelvis or to a field that includes more than 30% of the bone marrow or kidneys",
                "criterions": [
                    {
                        "exact_snippets": "Previously received external beam irradiation to the pelvis",
                        "criterion": "external beam irradiation to the pelvis",
                        "requirement": {
                            "requirement_type": "history of treatment",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Previously received external beam irradiation ... to a field that includes more than 30% of the bone marrow",
                        "criterion": "external beam irradiation to bone marrow",
                        "requirement": {
                            "requirement_type": "history of treatment",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Previously received external beam irradiation ... to a field that includes more than 30% of the bone marrow",
                        "criterion": "external beam irradiation to bone marrow",
                        "requirement": {
                            "requirement_type": "field coverage",
                            "expected_value": {
                                "operator": ">",
                                "value": 30,
                                "unit": "% of bone marrow"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Previously received external beam irradiation ... to a field that includes ... kidneys",
                        "criterion": "external beam irradiation to kidneys",
                        "requirement": {
                            "requirement_type": "history of treatment",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Previously received external beam irradiation to the pelvis",
                        "criterion": "external beam irradiation to the pelvis",
                        "requirement": {
                            "requirement_type": "history of treatment",
                            "expected_value": true
                        }
                    },
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Previously received external beam irradiation ... to a field that includes more than 30% of the bone marrow",
                                "criterion": "external beam irradiation to bone marrow",
                                "requirement": {
                                    "requirement_type": "history of treatment",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "Previously received external beam irradiation ... to a field that includes more than 30% of the bone marrow",
                                "criterion": "external beam irradiation to bone marrow",
                                "requirement": {
                                    "requirement_type": "field coverage",
                                    "expected_value": {
                                        "operator": ">",
                                        "value": 30,
                                        "unit": "% of bone marrow"
                                    }
                                }
                            }
                        ]
                    },
                    {
                        "exact_snippets": "Previously received external beam irradiation ... to a field that includes ... kidneys",
                        "criterion": "external beam irradiation to kidneys",
                        "requirement": {
                            "requirement_type": "history of treatment",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Prosthetic heart valve(s)",
                "criterions": [
                    {
                        "exact_snippets": "Prosthetic heart valve(s)",
                        "criterion": "prosthetic heart valve",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Prosthetic heart valve(s)",
                        "criterion": "prosthetic heart valve",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "10. Any medical, psychological or social condition that in the opinion of the investigator, would preclude participation in this study",
                "criterions": [
                    {
                        "exact_snippets": "Any medical, psychological or social condition that in the opinion of the investigator, would preclude participation in this study",
                        "criterion": "medical, psychological or social condition",
                        "requirement": {
                            "requirement_type": "investigator opinion of preclusion",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Any medical, psychological or social condition that in the opinion of the investigator, would preclude participation in this study",
                        "criterion": "medical, psychological or social condition",
                        "requirement": {
                            "requirement_type": "investigator opinion of preclusion",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "12. Previous treatment with any of the following: PSMA-targeted radionuclide therapy, Strontium-89, Samarium-153, Rhenium-186, Rhenium-188, Radium-223, hemi-body irradiation",
                "criterions": [
                    {
                        "exact_snippets": "Previous treatment with any of the following: PSMA-targeted radionuclide therapy",
                        "criterion": "previous PSMA-targeted radionuclide therapy",
                        "requirement": {
                            "requirement_type": "history of treatment",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Previous treatment with any of the following: ... Strontium-89",
                        "criterion": "previous Strontium-89 treatment",
                        "requirement": {
                            "requirement_type": "history of treatment",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Previous treatment with any of the following: ... Samarium-153",
                        "criterion": "previous Samarium-153 treatment",
                        "requirement": {
                            "requirement_type": "history of treatment",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Previous treatment with any of the following: ... Rhenium-186",
                        "criterion": "previous Rhenium-186 treatment",
                        "requirement": {
                            "requirement_type": "history of treatment",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Previous treatment with any of the following: ... Rhenium-188",
                        "criterion": "previous Rhenium-188 treatment",
                        "requirement": {
                            "requirement_type": "history of treatment",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Previous treatment with any of the following: ... Radium-223",
                        "criterion": "previous Radium-223 treatment",
                        "requirement": {
                            "requirement_type": "history of treatment",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Previous treatment with any of the following: ... hemi-body irradiation",
                        "criterion": "previous hemi-body irradiation",
                        "requirement": {
                            "requirement_type": "history of treatment",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Previous treatment with any of the following: PSMA-targeted radionuclide therapy",
                        "criterion": "previous PSMA-targeted radionuclide therapy",
                        "requirement": {
                            "requirement_type": "history of treatment",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Previous treatment with any of the following: ... Strontium-89",
                        "criterion": "previous Strontium-89 treatment",
                        "requirement": {
                            "requirement_type": "history of treatment",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Previous treatment with any of the following: ... Samarium-153",
                        "criterion": "previous Samarium-153 treatment",
                        "requirement": {
                            "requirement_type": "history of treatment",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Previous treatment with any of the following: ... Rhenium-186",
                        "criterion": "previous Rhenium-186 treatment",
                        "requirement": {
                            "requirement_type": "history of treatment",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Previous treatment with any of the following: ... Rhenium-188",
                        "criterion": "previous Rhenium-188 treatment",
                        "requirement": {
                            "requirement_type": "history of treatment",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Previous treatment with any of the following: ... Radium-223",
                        "criterion": "previous Radium-223 treatment",
                        "requirement": {
                            "requirement_type": "history of treatment",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Previous treatment with any of the following: ... hemi-body irradiation",
                        "criterion": "previous hemi-body irradiation",
                        "requirement": {
                            "requirement_type": "history of treatment",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "14. Patient has a functionally or anatomically solitary kidney.",
                "criterions": [
                    {
                        "exact_snippets": "functionally or anatomically solitary kidney",
                        "criterion": "solitary kidney",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "functionally or anatomically solitary kidney",
                        "criterion": "solitary kidney",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Pericarditis/clinically significant pericardial effusion",
                "criterions": [
                    {
                        "exact_snippets": "Pericarditis",
                        "criterion": "pericarditis",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "clinically significant pericardial effusion",
                        "criterion": "pericardial effusion",
                        "requirement": {
                            "requirement_type": "severity",
                            "expected_value": "clinically significant"
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Pericarditis",
                        "criterion": "pericarditis",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "clinically significant pericardial effusion",
                        "criterion": "pericardial effusion",
                        "requirement": {
                            "requirement_type": "severity",
                            "expected_value": "clinically significant"
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Myocardial infarction or unstable angina ≤6 months prior to treatment initiation",
                "criterions": [
                    {
                        "exact_snippets": "Myocardial infarction ... ≤6 months prior to treatment initiation",
                        "criterion": "myocardial infarction",
                        "requirement": {
                            "requirement_type": "time since event",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Myocardial infarction ... ≤6 months prior to treatment initiation",
                        "criterion": "myocardial infarction",
                        "requirement": {
                            "requirement_type": "occurrence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "unstable angina ≤6 months prior to treatment initiation",
                        "criterion": "unstable angina",
                        "requirement": {
                            "requirement_type": "time since event",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    },
                    {
                        "exact_snippets": "unstable angina ≤6 months prior to treatment initiation",
                        "criterion": "unstable angina",
                        "requirement": {
                            "requirement_type": "occurrence",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Myocardial infarction ... ≤6 months prior to treatment initiation",
                                "criterion": "myocardial infarction",
                                "requirement": {
                                    "requirement_type": "occurrence",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "Myocardial infarction ... ≤6 months prior to treatment initiation",
                                "criterion": "myocardial infarction",
                                "requirement": {
                                    "requirement_type": "time since event",
                                    "expected_value": {
                                        "operator": "<=",
                                        "value": 6,
                                        "unit": "months"
                                    }
                                }
                            }
                        ]
                    },
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "unstable angina ≤6 months prior to treatment initiation",
                                "criterion": "unstable angina",
                                "requirement": {
                                    "requirement_type": "occurrence",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "unstable angina ≤6 months prior to treatment initiation",
                                "criterion": "unstable angina",
                                "requirement": {
                                    "requirement_type": "time since event",
                                    "expected_value": {
                                        "operator": "<=",
                                        "value": 6,
                                        "unit": "months"
                                    }
                                }
                            }
                        ]
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "4. Known evidence of an active infection requiring systemic therapy such as uncontrolled human immunodeficiency virus (HIV), active hepatitis, or fungal infection. Uncomplicated urinary tract infection (UTI) does not qualify as an excluding infection.",
                "criterions": [
                    {
                        "exact_snippets": "Known evidence of an active infection requiring systemic therapy",
                        "criterion": "active infection",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Known evidence of an active infection requiring systemic therapy",
                        "criterion": "active infection",
                        "requirement": {
                            "requirement_type": "requires systemic therapy",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "uncontrolled human immunodeficiency virus (HIV)",
                        "criterion": "human immunodeficiency virus (HIV) infection",
                        "requirement": {
                            "requirement_type": "control status",
                            "expected_value": "uncontrolled"
                        }
                    },
                    {
                        "exact_snippets": "active hepatitis",
                        "criterion": "hepatitis",
                        "requirement": {
                            "requirement_type": "activity status",
                            "expected_value": "active"
                        }
                    },
                    {
                        "exact_snippets": "fungal infection",
                        "criterion": "fungal infection",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Uncomplicated urinary tract infection (UTI) does not qualify as an excluding infection",
                        "criterion": "uncomplicated urinary tract infection (UTI)",
                        "requirement": {
                            "requirement_type": "exclusion status",
                            "expected_value": false
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Known evidence of an active infection requiring systemic therapy",
                                "criterion": "active infection",
                                "requirement": {
                                    "requirement_type": "presence",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "Known evidence of an active infection requiring systemic therapy",
                                "criterion": "active infection",
                                "requirement": {
                                    "requirement_type": "requires systemic therapy",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "Uncomplicated urinary tract infection (UTI) does not qualify as an excluding infection",
                                "criterion": "uncomplicated urinary tract infection (UTI)",
                                "requirement": {
                                    "requirement_type": "exclusion status",
                                    "expected_value": false
                                }
                            }
                        ]
                    },
                    {
                        "exact_snippets": "uncontrolled human immunodeficiency virus (HIV)",
                        "criterion": "human immunodeficiency virus (HIV) infection",
                        "requirement": {
                            "requirement_type": "control status",
                            "expected_value": "uncontrolled"
                        }
                    },
                    {
                        "exact_snippets": "active hepatitis",
                        "criterion": "hepatitis",
                        "requirement": {
                            "requirement_type": "activity status",
                            "expected_value": "active"
                        }
                    },
                    {
                        "exact_snippets": "fungal infection",
                        "criterion": "fungal infection",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Endocarditis",
                "criterions": [
                    {
                        "exact_snippets": "Endocarditis",
                        "criterion": "endocarditis",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "not_criteria": {
                    "exact_snippets": "Endocarditis",
                    "criterion": "endocarditis",
                    "requirement": {
                        "requirement_type": "presence",
                        "expected_value": true
                    }
                }
            }
        },
        {
            "identified_line": {
                "line": "8. Has received major surgery within 90 days of first administration of study drug",
                "criterions": [
                    {
                        "exact_snippets": "Has received major surgery within 90 days of first administration of study drug",
                        "criterion": "major surgery",
                        "requirement": {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 90,
                                "unit": "days"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Has received major surgery within 90 days of first administration of study drug",
                        "criterion": "major surgery",
                        "requirement": {
                            "requirement_type": "occurrence",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Has received major surgery within 90 days of first administration of study drug",
                        "criterion": "major surgery",
                        "requirement": {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 90,
                                "unit": "days"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Has received major surgery within 90 days of first administration of study drug",
                        "criterion": "major surgery",
                        "requirement": {
                            "requirement_type": "occurrence",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Current or prior history of infection or other clinically significant adverse event associated with an exogenous implant or device that cannot be removed",
                "criterions": [
                    {
                        "exact_snippets": "Current or prior history of infection ... associated with an exogenous implant or device that cannot be removed",
                        "criterion": "infection associated with an exogenous implant or device",
                        "requirement": {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Current or prior history of infection ... associated with an exogenous implant or device that cannot be removed",
                        "criterion": "infection associated with an exogenous implant or device",
                        "requirement": {
                            "requirement_type": "removability of implant or device",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "other clinically significant adverse event associated with an exogenous implant or device that cannot be removed",
                        "criterion": "clinically significant adverse event associated with an exogenous implant or device",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "other clinically significant adverse event associated with an exogenous implant or device that cannot be removed",
                        "criterion": "clinically significant adverse event associated with an exogenous implant or device",
                        "requirement": {
                            "requirement_type": "removability of implant or device",
                            "expected_value": false
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Current or prior history of infection ... associated with an exogenous implant or device that cannot be removed",
                                "criterion": "infection associated with an exogenous implant or device",
                                "requirement": {
                                    "requirement_type": "history",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "Current or prior history of infection ... associated with an exogenous implant or device that cannot be removed",
                                "criterion": "infection associated with an exogenous implant or device",
                                "requirement": {
                                    "requirement_type": "removability of implant or device",
                                    "expected_value": false
                                }
                            }
                        ]
                    },
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "other clinically significant adverse event associated with an exogenous implant or device that cannot be removed",
                                "criterion": "clinically significant adverse event associated with an exogenous implant or device",
                                "requirement": {
                                    "requirement_type": "presence",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "other clinically significant adverse event associated with an exogenous implant or device that cannot be removed",
                                "criterion": "clinically significant adverse event associated with an exogenous implant or device",
                                "requirement": {
                                    "requirement_type": "removability of implant or device",
                                    "expected_value": false
                                }
                            }
                        ]
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "9. Prior allogeneic stem cell transplantation or recipients of organ transplants or autologous stem cell transplantation at any time MD Anderson Protocol Number: 2022-0500 2022-0500 Version Date 8/29/2023 26",
                "criterions": [
                    {
                        "exact_snippets": "Prior allogeneic stem cell transplantation",
                        "criterion": "allogeneic stem cell transplantation",
                        "requirement": {
                            "requirement_type": "history of procedure",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "recipients of organ transplants",
                        "criterion": "organ transplant",
                        "requirement": {
                            "requirement_type": "history of procedure",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "autologous stem cell transplantation at any time",
                        "criterion": "autologous stem cell transplantation",
                        "requirement": {
                            "requirement_type": "history of procedure",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Prior allogeneic stem cell transplantation",
                        "criterion": "allogeneic stem cell transplantation",
                        "requirement": {
                            "requirement_type": "history of procedure",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "recipients of organ transplants",
                        "criterion": "organ transplant",
                        "requirement": {
                            "requirement_type": "history of procedure",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "autologous stem cell transplantation at any time",
                        "criterion": "autologous stem cell transplantation",
                        "requirement": {
                            "requirement_type": "history of procedure",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Patients with HIV must agree to adhere to anti-retroviral therapy for the entirety of their participation in the protocol unless dictated by treatment toxicities.",
                "criterions": [
                    {
                        "exact_snippets": "Patients with HIV",
                        "criterion": "HIV infection",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "must agree to adhere to anti-retroviral therapy for the entirety of their participation in the protocol unless dictated by treatment toxicities",
                        "criterion": "adherence to anti-retroviral therapy",
                        "requirement": {
                            "requirement_type": "agreement to adhere",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "must agree to adhere to anti-retroviral therapy for the entirety of their participation in the protocol unless dictated by treatment toxicities",
                        "criterion": "adherence to anti-retroviral therapy",
                        "requirement": {
                            "requirement_type": "duration",
                            "expected_value": "entirety of participation in the protocol"
                        }
                    },
                    {
                        "exact_snippets": "must agree to adhere to anti-retroviral therapy for the entirety of their participation in the protocol unless dictated by treatment toxicities",
                        "criterion": "adherence to anti-retroviral therapy",
                        "requirement": {
                            "requirement_type": "exception",
                            "expected_value": "unless dictated by treatment toxicities"
                        }
                    }
                ]
            },
            "logical_structure": {
                "condition": {
                    "exact_snippets": "Patients with HIV",
                    "criterion": "HIV infection",
                    "requirement": {
                        "requirement_type": "presence",
                        "expected_value": true
                    }
                },
                "then_criteria": {
                    "or_criteria": [
                        {
                            "not_criteria": {
                                "and_criteria": [
                                    {
                                        "exact_snippets": "must agree to adhere to anti-retroviral therapy for the entirety of their participation in the protocol unless dictated by treatment toxicities",
                                        "criterion": "adherence to anti-retroviral therapy",
                                        "requirement": {
                                            "requirement_type": "agreement to adhere",
                                            "expected_value": true
                                        }
                                    },
                                    {
                                        "exact_snippets": "must agree to adhere to anti-retroviral therapy for the entirety of their participation in the protocol unless dictated by treatment toxicities",
                                        "criterion": "adherence to anti-retroviral therapy",
                                        "requirement": {
                                            "requirement_type": "duration",
                                            "expected_value": "entirety of participation in the protocol"
                                        }
                                    }
                                ]
                            }
                        },
                        {
                            "not_criteria": {
                                "exact_snippets": "must agree to adhere to anti-retroviral therapy for the entirety of their participation in the protocol unless dictated by treatment toxicities",
                                "criterion": "adherence to anti-retroviral therapy",
                                "requirement": {
                                    "requirement_type": "exception",
                                    "expected_value": "unless dictated by treatment toxicities"
                                }
                            }
                        }
                    ]
                },
                "else_criteria": null
            }
        },
        {
            "identified_line": {
                "line": "* Patients with HIV must be on an effective anti-retroviral regimen atleast four weeks prior to enrollment, HIV viral load less than 400 copies/mL and CD4+ T cell counts greater than 350 cell/uL.",
                "criterions": [
                    {
                        "exact_snippets": "Patients with HIV must be on an effective anti-retroviral regimen atleast four weeks prior to enrollment",
                        "criterion": "anti-retroviral regimen",
                        "requirement": {
                            "requirement_type": "effectiveness",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Patients with HIV must be on an effective anti-retroviral regimen atleast four weeks prior to enrollment",
                        "criterion": "anti-retroviral regimen",
                        "requirement": {
                            "requirement_type": "duration_prior_to_enrollment",
                            "expected_value": {
                                "operator": ">=",
                                "value": 4,
                                "unit": "weeks"
                            }
                        }
                    },
                    {
                        "exact_snippets": "HIV viral load less than 400 copies/mL",
                        "criterion": "HIV viral load",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 400,
                                "unit": "copies/mL"
                            }
                        }
                    },
                    {
                        "exact_snippets": "CD4+ T cell counts greater than 350 cell/uL",
                        "criterion": "CD4+ T cell count",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 350,
                                "unit": "cell/uL"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "not_criteria": {
                            "and_criteria": [
                                {
                                    "and_criteria": [
                                        {
                                            "exact_snippets": "Patients with HIV must be on an effective anti-retroviral regimen atleast four weeks prior to enrollment",
                                            "criterion": "anti-retroviral regimen",
                                            "requirement": {
                                                "requirement_type": "effectiveness",
                                                "expected_value": true
                                            }
                                        },
                                        {
                                            "exact_snippets": "Patients with HIV must be on an effective anti-retroviral regimen atleast four weeks prior to enrollment",
                                            "criterion": "anti-retroviral regimen",
                                            "requirement": {
                                                "requirement_type": "duration_prior_to_enrollment",
                                                "expected_value": {
                                                    "operator": ">=",
                                                    "value": 4,
                                                    "unit": "weeks"
                                                }
                                            }
                                        },
                                        {
                                            "exact_snippets": "HIV viral load less than 400 copies/mL",
                                            "criterion": "HIV viral load",
                                            "requirement": {
                                                "requirement_type": "quantity",
                                                "expected_value": {
                                                    "operator": "<",
                                                    "value": 400,
                                                    "unit": "copies/mL"
                                                }
                                            }
                                        },
                                        {
                                            "exact_snippets": "CD4+ T cell counts greater than 350 cell/uL",
                                            "criterion": "CD4+ T cell count",
                                            "requirement": {
                                                "requirement_type": "quantity",
                                                "expected_value": {
                                                    "operator": ">",
                                                    "value": 350,
                                                    "unit": "cell/uL"
                                                }
                                            }
                                        }
                                    ]
                                }
                            ]
                        }
                    }
                ]
            }
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [
        {
            "identified_line": {
                "line": "9. Localized or locally advanced disease deemed by the surgeon to be resectable. Patients must be appropriate candidates for and plan to undergo radical prostatectomy and pelvic lymph node dissection",
                "criterions": [
                    {
                        "exact_snippets": "Localized or locally advanced disease",
                        "criterion": "disease stage",
                        "requirement": {
                            "requirement_type": "stage",
                            "expected_value": [
                                "localized",
                                "locally advanced"
                            ]
                        }
                    },
                    {
                        "exact_snippets": "deemed by the surgeon to be resectable",
                        "criterion": "tumor resectability",
                        "requirement": {
                            "requirement_type": "resectability",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Patients must be appropriate candidates for and plan to undergo radical prostatectomy and pelvic lymph node dissection",
                        "criterion": "surgical candidacy and plan",
                        "requirement": {
                            "requirement_type": "candidate for radical prostatectomy",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Patients must be appropriate candidates for and plan to undergo radical prostatectomy and pelvic lymph node dissection",
                        "criterion": "surgical candidacy and plan",
                        "requirement": {
                            "requirement_type": "candidate for pelvic lymph node dissection",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Patients must be appropriate candidates for and plan to undergo radical prostatectomy and pelvic lymph node dissection",
                        "criterion": "surgical candidacy and plan",
                        "requirement": {
                            "requirement_type": "plan to undergo radical prostatectomy",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Patients must be appropriate candidates for and plan to undergo radical prostatectomy and pelvic lymph node dissection",
                        "criterion": "surgical candidacy and plan",
                        "requirement": {
                            "requirement_type": "plan to undergo pelvic lymph node dissection",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        },
        {
            "identified_line": {
                "line": "* Platelet count ≥150 x 109/L",
                "criterions": [
                    {
                        "exact_snippets": "Platelet count ≥150 x 109/L",
                        "criterion": "platelet count",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 150,
                                "unit": "x 10^9/L"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Platelet count \u001e150 x 109/L",
                        "criterion": "platelet count",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 150,
                                "unit": "x 10^9/L"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "2. Histologically documented prostatic adenocarcinoma with an NCCN risk group of high-risk or very high-risk. NCCN High Risk and Very High-Risk criteria shown below. (Network, N.C.C. (2021).",
                "criterions": [
                    {
                        "exact_snippets": "Histologically documented prostatic adenocarcinoma",
                        "criterion": "prostatic adenocarcinoma",
                        "requirement": {
                            "requirement_type": "histological documentation",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "NCCN risk group of high-risk or very high-risk",
                        "criterion": "NCCN risk group",
                        "requirement": {
                            "requirement_type": "risk group category",
                            "expected_value": [
                                "high-risk",
                                "very high-risk"
                            ]
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        },
        {
            "identified_line": {
                "line": "1. Men ≥18 years of age",
                "criterions": [
                    {
                        "exact_snippets": "Men",
                        "criterion": "sex",
                        "requirement": {
                            "requirement_type": "value",
                            "expected_value": "male"
                        }
                    },
                    {
                        "exact_snippets": "≥18 years of age",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Men",
                        "criterion": "sex",
                        "requirement": {
                            "requirement_type": "value",
                            "expected_value": "male"
                        }
                    },
                    {
                        "exact_snippets": "\u001e18 years of age",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "5. No evidence of metastatic disease or clinically positive lymph nodes as documented by technetium99m (99mTc) bone scan and by computed tomography (CT) or magnetic resonance imaging (MRI) scans. Imaging may be obtained up to 60 days prior to randomization",
                "criterions": [
                    {
                        "exact_snippets": "No evidence of metastatic disease",
                        "criterion": "metastatic disease",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "No evidence of ... clinically positive lymph nodes",
                        "criterion": "clinically positive lymph nodes",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "as documented by technetium99m (99mTc) bone scan and by computed tomography (CT) or magnetic resonance imaging (MRI) scans. Imaging may be obtained up to 60 days prior to randomization",
                        "criterion": "imaging for disease assessment",
                        "requirement": {
                            "requirement_type": "modality",
                            "expected_value": [
                                "technetium99m (99mTc) bone scan",
                                "computed tomography (CT)",
                                "magnetic resonance imaging (MRI)"
                            ]
                        }
                    },
                    {
                        "exact_snippets": "as documented by technetium99m (99mTc) bone scan and by computed tomography (CT) or magnetic resonance imaging (MRI) scans. Imaging may be obtained up to 60 days prior to randomization",
                        "criterion": "imaging for disease assessment",
                        "requirement": {
                            "requirement_type": "time window",
                            "expected_value": {
                                "operator": "<=",
                                "value": 60,
                                "unit": "days prior to randomization"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        },
        {
            "identified_line": {
                "line": "* Hemoglobin ≥11 g/dL",
                "criterions": [
                    {
                        "exact_snippets": "Hemoglobin ≥11 g/dL",
                        "criterion": "hemoglobin",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 11,
                                "unit": "g/dL"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Hemoglobin \u001e11 g/dL",
                        "criterion": "hemoglobin",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 11,
                                "unit": "g/dL"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "10. No prior treatment for prostate cancer including prior surgery (excluding transurethral resection of the prostate [TURP]), cryoablation, pelvic lymph node dissection, radiation therapy, hormonal therapy or chemotherapy",
                "criterions": [
                    {
                        "exact_snippets": "No prior treatment for prostate cancer including prior surgery (excluding transurethral resection of the prostate [TURP]), cryoablation, pelvic lymph node dissection, radiation therapy, hormonal therapy or chemotherapy",
                        "criterion": "prior treatment for prostate cancer",
                        "requirement": {
                            "requirement_type": "history",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "No prior treatment for prostate cancer including prior surgery (excluding transurethral resection of the prostate [TURP]), cryoablation, pelvic lymph node dissection, radiation therapy, hormonal therapy or chemotherapy",
                        "criterion": "prior treatment for prostate cancer",
                        "requirement": {
                            "requirement_type": "treatment_types",
                            "expected_value": [
                                "surgery (excluding TURP)",
                                "cryoablation",
                                "pelvic lymph node dissection",
                                "radiation therapy",
                                "hormonal therapy",
                                "chemotherapy"
                            ]
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        },
        {
            "identified_line": {
                "line": "* >4 cores with Grade Group 4 or 5",
                "criterions": [
                    {
                        "exact_snippets": ">4 cores with Grade Group 4 or 5",
                        "criterion": "number of cores with Grade Group 4 or 5",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 4,
                                "unit": "cores"
                            }
                        }
                    },
                    {
                        "exact_snippets": ">4 cores with Grade Group 4 or 5",
                        "criterion": "number of cores with Grade Group 4 or 5",
                        "requirement": {
                            "requirement_type": "grade group",
                            "expected_value": [
                                "4",
                                "5"
                            ]
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        },
        {
            "identified_line": {
                "line": "3. Prostate biopsy within 90 days prior to randomization is allowed for entry requirements. Prostate biopsy must be reviewed at MD Anderson Cancer Center. Patients with small cell, neuroendocrine, or transitional cell carcinomas are not eligible",
                "criterions": [
                    {
                        "exact_snippets": "Prostate biopsy within 90 days prior to randomization is allowed for entry requirements",
                        "criterion": "prostate biopsy",
                        "requirement": {
                            "requirement_type": "time since biopsy",
                            "expected_value": {
                                "operator": "<=",
                                "value": 90,
                                "unit": "days"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Prostate biopsy within 90 days prior to randomization is allowed for entry requirements",
                        "criterion": "prostate biopsy",
                        "requirement": {
                            "requirement_type": "procedure type",
                            "expected_value": "prostate biopsy"
                        }
                    },
                    {
                        "exact_snippets": "Prostate biopsy must be reviewed at MD Anderson Cancer Center",
                        "criterion": "prostate biopsy review location",
                        "requirement": {
                            "requirement_type": "review location",
                            "expected_value": "MD Anderson Cancer Center"
                        }
                    },
                    {
                        "exact_snippets": "Patients with small cell, neuroendocrine, or transitional cell carcinomas are not eligible",
                        "criterion": "histology type",
                        "requirement": {
                            "requirement_type": "exclusion",
                            "expected_value": [
                                "small cell carcinoma",
                                "neuroendocrine carcinoma",
                                "transitional cell carcinoma"
                            ]
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        },
        {
            "identified_line": {
                "line": "7. Distant metastatic disease or clinically positive lymph nodes not identified by conventional imaging including by technetium-99m (99mTc) bone scan and by computed tomography (CT) or magnetic resonance imaging (MRI) scans but identified PSMA PET is allowed based on provider discretion",
                "criterions": [
                    {
                        "exact_snippets": "Distant metastatic disease ... not identified by conventional imaging including by technetium-99m (99mTc) bone scan and by computed tomography (CT) or magnetic resonance imaging (MRI) scans but identified PSMA PET is allowed",
                        "criterion": "distant metastatic disease",
                        "requirement": {
                            "requirement_type": "detection_method",
                            "expected_value": [
                                "not identified by conventional imaging including by technetium-99m (99mTc) bone scan and by computed tomography (CT) or magnetic resonance imaging (MRI) scans",
                                "identified by PSMA PET"
                            ]
                        }
                    },
                    {
                        "exact_snippets": "clinically positive lymph nodes not identified by conventional imaging including by technetium-99m (99mTc) bone scan and by computed tomography (CT) or magnetic resonance imaging (MRI) scans but identified PSMA PET is allowed",
                        "criterion": "clinically positive lymph nodes",
                        "requirement": {
                            "requirement_type": "detection_method",
                            "expected_value": [
                                "not identified by conventional imaging including by technetium-99m (99mTc) bone scan and by computed tomography (CT) or magnetic resonance imaging (MRI) scans",
                                "identified by PSMA PET"
                            ]
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        }
    ],
    "failed_exclusion": [
        {
            "identified_line": {
                "line": "7. Other prior malignancy (exceptions: adequately treated basal cell or squamous cell skin cancer, superficial bladder cancer, or any other cancer in situ currently in complete remission) ≤2 years prior to enrollment",
                "criterions": [
                    {
                        "exact_snippets": "Other prior malignancy ... ≤2 years prior to enrollment",
                        "criterion": "prior malignancy",
                        "requirement": {
                            "requirement_type": "time since diagnosis or treatment",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2,
                                "unit": "years"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Other prior malignancy ... ≤2 years prior to enrollment",
                        "criterion": "prior malignancy",
                        "requirement": {
                            "requirement_type": "exceptions",
                            "expected_value": [
                                "adequately treated basal cell skin cancer",
                                "adequately treated squamous cell skin cancer",
                                "superficial bladder cancer",
                                "any other cancer in situ currently in complete remission"
                            ]
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        },
        {
            "identified_line": {
                "line": "1. Prior hormone therapy for prostate cancer including orchiectomy, antiandrogens, ketoconazole, or estrogens (5-α reductase inhibitors allowed), or LHRH agonists/antagonists",
                "criterions": [
                    {
                        "exact_snippets": "Prior hormone therapy for prostate cancer including orchiectomy, antiandrogens, ketoconazole, or estrogens (5-α reductase inhibitors allowed), or LHRH agonists/antagonists",
                        "criterion": "prior hormone therapy for prostate cancer",
                        "requirement": {
                            "requirement_type": "history of treatment",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Prior hormone therapy for prostate cancer including orchiectomy, antiandrogens, ketoconazole, or estrogens (5-α reductase inhibitors allowed), or LHRH agonists/antagonists",
                        "criterion": "prior hormone therapy for prostate cancer",
                        "requirement": {
                            "requirement_type": "treatment types",
                            "expected_value": [
                                "orchiectomy",
                                "antiandrogens",
                                "ketoconazole",
                                "estrogens",
                                "LHRH agonists",
                                "LHRH antagonists"
                            ]
                        }
                    },
                    {
                        "exact_snippets": "Prior hormone therapy for prostate cancer including orchiectomy, antiandrogens, ketoconazole, or estrogens (5-α reductase inhibitors allowed), or LHRH agonists/antagonists",
                        "criterion": "prior hormone therapy for prostate cancer",
                        "requirement": {
                            "requirement_type": "exceptions",
                            "expected_value": "5-α reductase inhibitors allowed"
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        },
        {
            "identified_line": {
                "line": "* Congestive heart failure (New York Heart Association class III-IV)",
                "criterions": [
                    {
                        "exact_snippets": "Congestive heart failure (New York Heart Association class III-IV)",
                        "criterion": "congestive heart failure",
                        "requirement": {
                            "requirement_type": "severity",
                            "expected_value": [
                                "New York Heart Association class III",
                                "New York Heart Association class IV"
                            ]
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        },
        {
            "identified_line": {
                "line": "* Patients on Tenofovir will be excluded as there is a known risk of proximal renal tubule dysfunction leading to renal toxicity. Given that PSMA is expressed on the proximal tubule there is a theoretical risk of overlapping toxicity.",
                "criterions": [
                    {
                        "exact_snippets": "Patients on Tenofovir will be excluded",
                        "criterion": "Tenofovir use",
                        "requirement": {
                            "requirement_type": "current use",
                            "expected_value": false
                        }
                    }
                ]
            },
            "logical_structure": {
                "not_criteria": {
                    "exact_snippets": "Patients on Tenofovir will be excluded",
                    "criterion": "Tenofovir use",
                    "requirement": {
                        "requirement_type": "current use",
                        "expected_value": true
                    }
                }
            }
        }
    ],
    "failed_miscellaneous": []
}